Roquefort Therapeutics PLC (PK) (ROQAF)
USOTC
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | |
| Return on Assets (%) | -40.175 | -26.201 | -25.186 |
| Return on Equity (%) | -44.869 | -28.609 | -27.465 |
| Return on Invested Capital (%) | -31.105 | -28.592 | -27.497 |
| Operating Margin (%) | -91600 | N/A | -966 |
| Net Profit Margin (%) | -91600 | N/A | -872.5 |
| Book Value Per Share | 0.036 | 0.014 | 0.001 |
| Earnings Per Share | -0.013 | -0.013 | -0.014 |
| Cash Per Share | 0.013 | 0.018 | 0.004 |
| Working Capital Per Share | 0.04 | 0.017 | 0.003 |
| Operating Profit Per Share | N/A | N/A | 0.002 |
| EBIT Per Share | -0.013 | -0.013 | -0.015 |
| EBITDA Per Share | -0.013 | -0.013 | -0.015 |
| Free Cash Flow Per Share | -0.013 | -0.013 | -0.013 |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| Current Ratio | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A |
| Shares Outstanding | 71.9M | 129.15M | 129.15M |
| Market Cap | 6.46M |
| Price to Earnings Ratio | -3.33 |
| Price to Sales Ratio | 30 |
| Price to Cash Ratio | 10.71 |
| Price to Book Ratio | 1.06 |
| Dividend Yield | - |
| Shares Outstanding | 129.15M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -51.64% |
| 52 Week High | 0.1034 |
| 52 Week Low | 0.049 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
